COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Jilin Zixin Pharmaceutical Co., Ltd.

Page view
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) applied for the proposed non-public offering of shares through the company to the Shenzhen Stock Exchange. The company’s shares were suspended from the opening on August 21, 2014. For details, see On August 22, 2014, the company disclosed in the company's designated media "Securities Times", "China Securities Journal", "Shanghai Securities News", "Securities Daily" and Juchao Information Network ( Announcement on Suspension of Major Events (Announcement No.: 2014-042).
As the preparatory work for the company's non-public offering of shares has not been completed, and there is still uncertainty in the matter, in order to prevent abnormal fluctuations in stock prices and effectively protect the interests of investors, the application is made to the Shenzhen Stock Exchange, according to the Shenzhen Stock Exchange. The relevant provisions of the "Stock Listing Rules" and the "Guidelines for the Standardized Operation of Listed Companies of SME Boards" will continue to be suspended from trading on August 28, 2014. During the suspension of trading, the company will convene a board meeting as soon as possible to consider matters related to non-public offering of shares. After the relevant matters are confirmed, the company will promptly disclose relevant announcements and resume trading in accordance with relevant regulations. Investors are advised to pay attention to follow-up announcements and pay attention to investment risks.
Special announcement
Jilin Zixin Pharmaceutical Co., Ltd.
Board of Directors
                                   August 28, 2014